Purpose: Adipokines, especially leptin and adiponectin, have gained increasing importance in pathophysiology of various neurological diseases including epilepsy. There are experimental data suggesting a role for leptin in the genesis of seizures and neuroprotection related to seizures. However there are no clinical studies on the effects of epileptic seizures on adipokines. Methods: We measured cerebrospinal fluid (CSF) and plasma levels of leptin, adiponectin and adipsin after provoked or unprovoked primary or secondarily generalized tonic-clonic seizures in 13 female patients and seven controls. The samples were taken within 24 h after the seizure onset. Results: Leptin plasma levels correlated negatively with the time to sample withdrawal, i.e. the longer the time interval between the seizure and the sample the lower the leptin levels in the patients. Interestingly, plasma adiponectin levels were significantly increased after the seizure episode. Conclusion: This study provides further evidence that there are seizure-induced acute changes in adipokine metabolism. Leptin concentrations seem to decrease during the first 24 h after the seizure whereas adiponectin levels increase. The meaning of this response is far from clear, but it might be an endogenous attempt to prevent harmful effects of epileptic seizures in the central nervous system. ß 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Mean age of the patients and controls was 42.7 and 37.1 years, respectively. Most patients had a single seizure (8/13), two had a second seizure in the emergency room, two had status epilepticus, and one patient had four seizures in succession. None had antiepileptic medication at the time of sampling. Three patients had provoked seizures (alcohol withdrawal syndrome). All other patients were later diagnosed with epilepsy. Their brain imaging did not reveal any symptomatic etiology of epilepsy except in two cases (glioblastoma and multiple sclerosis).
All patients were fully informed of the risks and potential benefits of the CSF examination, and written informed consent was obtained from each subject. The study protocol was approved by the Ethics Committee of Tampere University Hospital, Finland, and performed in accordance with the Helsinki declaration.
CSF and plasma sampling
The samples were collected and analyzed between the end of 2010 and during the year 2011. The CSF and plasma samples were taken within 24 h (mean 11.7 h) after the seizure onset. The samples were obtained between 9 a.m. and 12 p.m. in 10/13 patients and the rest between 2 and 6 p.m. The first 2 ml of CSF was used for routine examination and a further 200 ml for the present study. Blood was collected within 30 min of lumbar puncture. Concentrations of adiponectin, adipsin and leptin in CSF and plasma were determined by enzyme-linked immunosorbent assay (ELISA) using DuoSet ELISA, R&D Systems Europe Ltd., Abindgon, UK. Adipokines CSF/plasma ratio was also calculated.
Statistical methods
The parameters were not normally distributed, thus nonparametric methods were used. Statistical significance of the differences in adipokine levels between the groups were tested by using Mann-Whitney test. Correlation between numerical values was calculated by using Pearson correlation test. Statistical analysis was carried out with SPSS 17.0 software.
Results
The median levels of plasma and CSF adipokines in patients and controls are given in Table 1 . The plasma levels of adiponectin were significantly higher in patients than in controls (4.20 mg/ml and 2.83 mg/ml, p = 0.03). There were no statistically significant differences in the levels of the other adipokines in plasma or CSF between the patients and the controls. The results remained the same in reference to BMI.
Age of the patients and controls correlated with adipsin and adiponectin levels in CSF (r = 0.66, p = 0.002 and r = 0.46, p = 0.04, respectively). Only leptin levels in plasma correlated with BMI (r = 0.54, p = 0.01). There was also a correlation between plasma and CSF leptin levels (r = 0.64, p = 0.002) but none between other plasma and CSF adipokine levels. Age (p = 0.45) or BMI (p = 0.44) did not differ between the patient group and control group (MannWhitney). The number of seizures did not affect adipokine levels, nor did the time of the sampling. Interestingly, the time interval between the seizures and blood/CSF samples correlated negatively with leptin levels in plasma (r = À0.64, p = 0.019, Fig. 1 ). CSF/ plasma ratios of adipokines were not different between patients and controls.
Discussion
Adipokines have gained increasing importance in the pathophysiology of and in the drug development for various neurological diseases including epilepsy. To the best of our knowledge, this is the first study to evaluate plasma and CSF levels of adipokines shortly after epileptic seizures in humans. Interestingly, plasma adiponectin levels were increased following epileptic seizures as compared to the controls. Also, leptin levels in the plasma and CSF samples correlated negatively with the time to sample withdrawal.
In addition to regulating energy homeostasis, both leptin and adiponectin have widespread actions in the CNS. Leptin could be neuroprotective and may enhance neuronal survival, and it is implicated in the regulation of neuronal excitability [2, 7, 8] . Ketogenic diet used for treatment in some forms of epilepsy, increases leptin levels in serum, hinting that leptin may contribute to the anticonvulsant effects of the diet [9, 10] . In fact, leptin receptor activation has been suggested as a target for treatment of epilepsy, at least in acute seizures [10] , although a dose-related proconvulsant activity of leptin has also been reported [11] . Leptin levels in plasma or CSF did not differ in our epilepsy group compared to controls. However, plasma leptin levels correlated negatively with the time to sample collection. We do not have baseline leptin levels from patients with epileptic seizures. Therefore two alternative explanations emerge. Either the patients have decreased concentrations of leptin before the seizure with transient initial increase and subsequent decrease, or leptin levels decreased after the seizure. Whether this is a harmful or protective response remains unclear, but could be an endogenous attempt to prevent harmful effects in the CNS. Studies addressing adiponectin in connection with seizures are scant. Adiponectin seems to have modulating effects in seizure severity and cell pathology based on studies with metabolic syndrome or kainic acid induced seizures [2, 12] . Hietaharju and coworkers [13] suggested that adiponectin could be synthesized in CSF, in addition to adipose tissue, based on the observation that adiponectin levels in CSF did not correlate with the levels in plasma which was confirmed in the present study. Adiponectin concentration in CSF has been 1000-fold less than in serum, which is in agreement with our results. Disturbed function of blood-brain barrier has been associated with elevated CSF/serum adiponectin ratio [14] . Plasma adiponectin level was higher in our patient group after seizures than in the controls. CSF/plasma ratio of adiponectin or any other adipokine was not elevated in patients; therefore, our results do not suggest an intrathecal synthesis of adipokines.
As another peripheral source (in addition to adipocytes), skeletal muscle cells have also been shown to express adiponectin. Interestingly, adiponectin levels have increased during recovery phase in trained athletes after 30 min rowing-exercise performed at anaerobic threshold [15] , and further, it is known that adiponectin increases contractility of smooth muscle cells [16] . It is possible that the release of adiponectin from skeletal muscle during primary or secondarily generalized tonic-clonic seizures in part explains the increased plasma levels detected in our patients. The increased adiponectin level could also enhance the contractility of muscle cells.
Circulating leptin levels show a diurnal rhythm [17] , although, no correlation to timing was found in our patients. Only a correlation between BMI and leptin was found, even though, the levels of leptin, adipsin and adiponectin have been reported to correlate with body weight [18] . The mean BMI in controls was somewhat higher compared to patients but the difference was not statistically significant and our results did not alter in relation to BMI.
Only female subjects were included in this study based on earlier observations of gender differences in the adipokine levels [19] . Other limitations of this study were small sample size and heterogeneous etiology of the seizures. The patients were newly diagnosed with epilepsy; consequently, the results might differ with chronic or refractory epilepsy patients. On the other hand, they did not have antiepileptic medication that could have an effect on the results. The control group had unspecific neurological symptoms that resulted in CSF examination, although, the examinations did not yield any significant findings that might affect the results of this study.
In conclusion, we found elevated adiponectin levels after epileptic seizures in female patients and our results suggest that an epileptic seizure may induce a transient change of leptin concentrations in plasma and CSF. Further studies are needed to confirm the results obtained in this pilot study and to gain understanding of the meaning of seizure-induced adipokine changes.
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